drugset / Trial / NCT01418521
Safety and Effectiveness of a Balanced 3rd Generation HES Solution (Tetraspan®) After Cardiac Surgery
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this randomized controlled trial in patients undergoing cardiac surgery is to show that a 3rd generation HES (Hydroxyethyl Starch) solution - Tetraspan® is as good as in terms of safety and effectiveness as the commonly used albumin based solution for volume replacement after the surgery.
Timeline
- Start
- 2011-08
- Primary completion
- 2013-07
- Completion
- 2013-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Ringer- albumin | Other / unclassified | 20 % | — |
| Subject | Tetraspan | Other / unclassified | 6 % | — |
Indications
No indication recorded.